Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Schrodinger (SDGR)
NASDAQ:SDGR
Schrodinger (SDGR) Stock Price & Analysis
1,782 Followers
SDGR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$18.21 - $56.47
Previous Close$22.4
Volume660.08K
Average Volume (3M)722.26K
Market Cap
$1.63B
Enterprise Value$1.32B
Total Cash (Recent Filing)$431.08M
Total Debt (Recent Filing)$125.92M
Price to Earnings (P/E)―
Beta2.10
Next Earnings
Aug 01, 2024EPS Estimate
-$0.85Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.99
Shares Outstanding72,679,390
10 Day Avg. Volume752,257
30 Day Avg. Volume722,256
Standard Deviation0.21
R-Squared0.16
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.51
Price to Sales (P/S)32.59
Price to Cash Flow (P/CF)-9.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue5.77
Enterprise Value/Gross Profit9.40
Enterprise Value/Ebitda-8.90
Forecast
1Y Price Target
$32.50Price Target Upside43.23% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Schrodinger News
PremiumStock Analysis & Ideas
Citigroup Recommends 3 Stocks to Buy — Including One With 77% Upside Potential
Bulls Say, Bears Say
Bulls Say
Big Pharma AdoptionBig Pharma adoption tailwinds are evident in increasing annual contract value per customer.
Core Business GrowthSchrödinger, Inc. is positioned for reacceleration in core business growth should new customer adds recover and churn fall with a rebounding biotech funding environment.
Software Platform ValidationSchrödinger, Inc. has the most validated software platform among technology-enabled drug discovery (TEDD) players and the advantages of incumbency.
Bears Say
Earnings ReportSchrodinger's first-quarter revenue of $36.6 million fell 44% year-over-year and missed the consensus estimate by approximately 14%.
Financial PerformanceSchrodinger reported total revenues of $36.6 million, significantly below market expectations of $43.5 million and $44.4 million.
Revenue MissThe company faced a substantial shortfall in drug discovery revenues, reporting only $3.3 million compared to market estimates of $8.1 million and $10.3 million.
---
Ownership Overview
26.14% Insiders
23.01% Mutual Funds
26.02% Other Institutional Investors
24.83% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SDGR FAQ
What was Schrodinger’s price range in the past 12 months?
Schrodinger lowest stock price was $18.21 and its highest was $56.47 in the past 12 months.
What is Schrodinger’s market cap?
Currently, no data Available
When is Schrodinger’s upcoming earnings report date?
Schrodinger’s upcoming earnings report date is Aug 01, 2024 which is in 10 days.
How were Schrodinger’s earnings last quarter?
Schrodinger released its earnings results on May 01, 2024. The company reported -$0.76 earnings per share for the quarter, missing the consensus estimate of -$0.742 by -$0.018.
Is Schrodinger overvalued?
According to Wall Street analysts Schrodinger’s price is currently Undervalued.
Does Schrodinger pay dividends?
Schrodinger does not currently pay dividends.
What is Schrodinger’s EPS estimate?
Schrodinger’s EPS estimate is -$0.85.
How many shares outstanding does Schrodinger have?
Schrodinger has 63,515,198 shares outstanding.
What happened to Schrodinger’s price movement after its last earnings report?
Schrodinger reported an EPS of -$0.76 in its last earnings report, missing expectations of -$0.742. Following the earnings report the stock price went down -8.195%.
Which hedge fund is a major shareholder of Schrodinger?
Among the largest hedge funds holding Schrodinger’s share is Bill & Melinda Gates Foundation Trust. It holds Schrodinger’s shares valued at 189M.
---
Schrodinger Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$32.50 (43.23% Upside)
$32.50 (43.23% Upside)
Blogger Sentiment
Bullish
SDGR Sentiment 77%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 139.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.3%
Last 30 Days ▼ 0.2%
Last 30 Days ▼ 0.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.93%
12-Months-Change
Fundamentals
Return on Equity
-25.93%
Trailing 12-Months
Asset Growth
-12.04%
Trailing 12-Months
Company Description
Schrodinger
Schrödinger, Inc. provides chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. Schrödinger was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in August 1990 and is headquartered in New York, NY.
---
SDGR Company Deck
---
SDGR Earnings Call
Q1 2024
0:00 / 0:00
---
SDGR Stock 12 Month Forecast
Average Price Target
$32.50
▲(43.23% Upside)
Technical Analysis
Best Analysts Covering SDGR
1 Year
1 Year Success Rate
8/16 ratings generated profit
1 Year Average Return
-0.70%
reiterated a buy rating 12 months ago
Copying Gaurav Goparaju's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -0.70% per trade.
---